How much funding has Hugel raised?

Hugel has raised $2.3B in total funding, most recently a Private Equity round.

Who are Hugel's investors?

Hugel's investors include CBC Group, GS Group, Bain Capital, Mubadala Capital.

Where is Hugel headquartered?

Hugel is headquartered in Chuncheon, South Korea.

What industry is Hugel in?

Hugel operates in Aesthetics, Biotech, Healthcare.

Hugel

Power That Makes You Shine

Chuncheon, South Korea · Founded 2001 · $2.3B raised

Aesthetics

Biotech

Healthcare

Headquarters: Chuncheon
Employees: 201–500
Founded: 2001
Business Model: B2B

Website: hugel-inc.com
Total Funding: $2.3B
Last Round: $1.5B Private EquityAug 2021
Rounds: 2

About

Hugel is a South Korean global leader in medical aesthetics founded in 2001, producing botulinum toxin (Botulax/Letybo), hyaluronic acid fillers, skin boosters, threads, and bio-cosmetics. Present in over 70 countries, Hugel received US FDA approval for Letybo in 2024, challenging established neurotoxin brands. The company serves healthcare professionals worldwide through academic programs and maintains strict international quality and manufacturing standards.

Summary

Hugel is an Aesthetics company based in Chuncheon, South Korea, founded in 2001. It has raised $2.3B in total across 2 rounds, most recently a $1.5B Private Equity round in Aug 2021. Investors include CBC Group, GS Group and Bain Capital.